LIGAND PHARMACEUTICALS INCORPORATED (LGND) /
The revenue of LIGAND PHARMACEUTICALS INCORPORATED over the past 10 years
Chart LIGAND PHARMACEUTICALS INCORPORATED: revenue, fiscal 2016–2025 Open the chart →LIGAND PHARMACEUTICALS INCORPORATED reported revenue of $268.09M in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $108.97M — up 146% over 9 years. Year over year, revenue rose 6 times and fell 3 times. The largest one-year move was in fiscal 2018: up 78%, from $141.1M to $251.45M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $268.09M |
| 2024ended Dec 31, 2024 | $167.13M |
| 2023ended Dec 31, 2023 | $131.31M |
| 2022ended Dec 31, 2022 | $196.25M |
| 2021ended Dec 31, 2021 | $241.54M |
| 2020ended Dec 31, 2020 | $163.56M |
| 2019ended Dec 31, 2019 | $120.28M |
| 2018ended Dec 31, 2018 | $251.45M |
| 2017ended Dec 31, 2017 | $141.1M |
| 2016ended Dec 31, 2016 | $108.97M |
Fiscal years as LIGAND PHARMACEUTICALS INCORPORATED reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on LIGAND PHARMACEUTICALS INCORPORATED
- The profitability of LIGAND PHARMACEUTICALS INCORPORATED
- The cash flow of LIGAND PHARMACEUTICALS INCORPORATED
- The debt of LIGAND PHARMACEUTICALS INCORPORATED
- All of LIGAND PHARMACEUTICALS INCORPORATED's financials, charted
Companies of a similar size
- SWXSouthwest Gas Holdings, Inc.
- MACMACERICH CO
- EXLSEXLSERVICE HOLDINGS, INC.
- TXNMTXNM Energy, Inc.
- LADLithia Motors, Inc.
Not investment advice. This page shows what LIGAND PHARMACEUTICALS INCORPORATED filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.